• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher James Frankenfield

Location
Waltham, MA
Summary
The estimated net worth of Christopher James Frankenfield is at least $69.4K dollars as of November 25, 2025. Christopher James Frankenfield is the Chief Financial Officer of Xilio Therapeutics, Inc. and owns shares of Xilio Therapeutics, Inc. (XLO) stock worth about $69.4K.
Signature
/s/ Kevin Brennan, Attorney-in-Fact
All Insider Reports
All Insider Reports

Notify me when Christopher James Frankenfield files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Christopher James Frankenfield

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
XLO Xilio Therapeutics, Inc. Chief Financial Officer $69.4K -$6.84K -8.97% Nov 21, 2025

Insider Transactions Reported by Christopher James Frankenfield:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.